Donley Matthew Maxwell sold AUPH
January 2, 2026 · Form 4 insider transaction
Donley Matthew Maxwell sold 42,787 shares of Aurinia Pharmaceuticals Inc. at $15.95 per share, a transaction worth $682.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
42,787
Price
$15.95
Total value
$682.5K
InsiderDonley Matthew Maxwell
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after695,801
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards.; Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 common shares were acquired on May 30, 2025 and 1,457 common shares were acquired on November 28, 2025.